Patent_application_number,Applicant_name,Year_of_application,Patent_system
EP3765623A1,GOVERNMENT OF CHINA,2021,EPO
EP3778629A1,PHARCHOICE THERAPEUTICS INC [CN],2021,EPO
EP3778866A1,QIBEBT,2021,EPO
EP3778912A1,AJINOMOTO,2021,EPO
EP3782465A1,UNIVERSITY OF POTSDAM,2021,EPO
EP3786290A1,MAX PLANCK SOCIETY,2021,EPO
EP3790394A1,"RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY; NEW BRUNSWICK, NJ",2021,EPO
EP3790891A1,BELLICUM PHARMACEUTICALS INC,2021,EPO
EP3793590A1,UNIVERSITY OF MINNESOTA,2021,EPO
EP3808741A1,AUSTRIAN ACADEMY OF SCIENCES,2021,EPO
EP3814370A2,ALTIUS INSTITUTE FOR BIOMEDICAL SCIENCES,2021,EPO
EP3827080A1,VIRIDOS,2021,EPO
EP3833689A2,JCR PHARMACEUTICALS CO LTD,2021,EPO
EP3833780A1,UNIVERSITY OF NEW MEXICO,2021,EPO
EP3851534A1,NAGOYA INSTITUTE OF TECHNOLOGY,2021,EPO
EP3852813A2,AERA HERPEUTICS INC [US],2021,EPO
EP3862437A1,SEIKAGAKU CORPORATION,2021,EPO
EP3864152A1,PEKIN UNIVERSITY,2021,EPO
EP3874033A1,CODEXIS INC [US],2021,EPO
EP3889256A1,UTILIZATION OF CARBON DIOXIDE INSTITUTE,2021,EPO
EP3894422A1,KHONA SCIENT LLC [US],2021,EPO